Buscador de publicacions

Publicacions

  • Villarroya J, Flachs P, Redondo-Angulo I, Giralt M, Medrikova D, Villarroya F, Kopecky J and Planavila A.

    Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.

    Lipids . 49(11): 1081-1089. Nº de cites: 17

    [doi:10.1007/s11745-014-3948-x]

  • Domingo P, Gutierrez Mdel M, Gallego-Escuredo JM, Torres F, Mateo MG, Villarroya J, Lamarca K, Domingo JC, Vidal F, Villarroya F and Giralt M.

    A 48-week study of fat molecular alterations in HIV naive patients starting tenofovir/emtricitabine with lopinavir/ritonavir or efavirenz.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 66(5): 457-465. Nº de cites: 12

    [doi:10.1097/QAI.0000000000000205]

  • Hondares E, Gallego-Escuredo JM, Flachs P, Frontini A, Cereijo R, Goday A, Perugini J, Kopecky P, Giralt M, Cinti S, Kopecky J and Villarroya F.

    Fibroblast growth factor-21 is expressed in neonatal and pheochromocytoma-induced adult human brown adipose tissue.

    METABOLISM-CLINICAL AND EXPERIMENTAL . 63(3): 312-317. Nº de cites: 58

    [doi:10.1016/j.metabol.2013.11.014]

  • Gallego-Escuredo JM, Villarroya J, Domingo P, Targarona EM, Alegre M, Domingo JC, Villarroya F and Giralt M.

    Differentially altered molecular signature of visceral adipose tissue in HIV-1-associated lipodystrophy.

    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES . 64(2): 142-148. Nº de cites: 24

    [doi:10.1097/QAI.0b013e31829bdb67]

  • Palomer FX, Capdevila-Busquets E, Alvarez-Guardia D, Barroso E, Pallàs M, Camins A, Davidson MM, Planavila A, Villarroya F and Vazquez M.

    Resveratrol induces nuclear factor-?B activity in human cardiac cells.

    INTERNATIONAL JOURNAL OF CARDIOLOGY . 167(6): 2507-2516. Nº de cites: 27

    [doi:10.1016/j.ijcard.2012.06.006]

  • Villarroya F and Vidal-Puig A.

    Beyond the sympathetic tone: the new brown fat activators.

    CELL METABOLISM . 17(5): 638-643. Nº de cites: 150

    [doi:10.1016/j.cmet.2013.02.020]

  • Gallego-Escuredo JM, Domingo P, Fontdevila J, Villarroya J, Domingo JC, Martinez E, Giralt M and Villarroya F.

    Hypertrophied facial fat in an HIV-1-infected patient after autologous transplantation from 'buffalo hump' retains a partial brown-fat-like molecular signature.

    ANTIVIRAL THERAPY . 18(4): 635-639. Nº de cites: 2

    [doi:10.3851/IMP2528]

  • Díaz-Delfín J, Domingo P, Mateo MG, Gutierrez Mdel M, Domingo JC, Giralt M and Villarroya F.

    Effects of rilpivirine on human adipocyte differentiation, gene expression, and release of adipokines and cytokines.

    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY . 56(6): 3369-3375. Nº de cites: 20

    [doi:10.1128/AAC.00104-12]

  • Armengol J, Villena JA, Hondares E, Carmona MC, Sul HS, Iglesias R, Giralt M and Villarroya F.

    Pref-1 in brown adipose tissue: specific involvement in brown adipocyte differentiation and regulatory role of C/EBPd.

    BIOCHEMICAL JOURNAL . 443(3): 799-810. Nº de cites: 20

    [doi:10.1042/BJ20111714]

  • Villarroya J, Dorado B, Vilà MR, Garcia-Arumí E, Domingo P, Giralt M, Hirano M and Villarroya F.

    Thymidine kinase 2 deficiency-induced mitochondrial DNA depletion causes abnormal development of adipose tissues and adipokine levels in mice.

    PLoS One . 6(12): . Nº de cites: 13

    [doi:10.1371/journal.pone.0029691]